当前位置:首页 - 行情中心 - 石药创新(300765) - 财务分析 - 现金流量表

石药创新

(300765)

  

流通市值:623.64亿  总市值:623.64亿
流通股本:14.05亿   总股本:14.05亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,314,811,453.78481,187,224.942,209,057,086.431,287,089,459.86
  收到的税费返还21,297,605.3815,739,469.6348,617,300.3138,160,567.57
  收到其他与经营活动有关的现金898,548,836.567,539,842.87269,595,141.52206,290,929.1
  经营活动现金流入小计4,234,657,895.72504,466,537.442,527,269,528.261,531,540,956.53
  购买商品、接受劳务支付的现金1,112,929,804.98520,177,108.912,015,049,062.231,138,146,688.1
  支付给职工以及为职工支付的现金171,415,150.5286,235,473.23293,349,232.84210,651,860.05
  支付的各项税费42,240,751.7124,796,958.33118,372,640.67101,108,775.34
  支付其他与经营活动有关的现金131,930,358.6152,776,770.85296,191,163.85256,755,192.97
  经营活动现金流出小计1,458,516,065.82683,986,311.322,722,962,099.591,706,662,516.46
  经营活动产生的现金流量净额2,776,141,829.9-179,519,773.88-195,692,571.33-175,121,559.93
二、投资活动产生的现金流量:
  收回投资收到的现金1,435,000,000385,000,0002,015,000,0001,435,000,000
  取得投资收益收到的现金12,197,309.511,540,00014,851,154.65,409,249.34
  处置固定资产、无形资产和其他长期资产收回的现金净额562,457.61-9,023,855.94903,000
  处置子公司及其他营业单位收到的现金净额229,880,000---
  收到的其他与投资活动有关的现金---12,668,657.69
  投资活动现金流入小计1,677,639,767.12386,540,0002,038,875,010.541,453,980,907.03
  购建固定资产、无形资产和其他长期资产支付的现金250,254,808.21107,468,522.92568,386,404.91274,853,304.43
  投资支付的现金2,596,000,000350,000,0001,780,000,0001,424,000,000
  取得子公司及其他营业单位支付的现金--29,000,000-
  投资活动现金流出小计2,846,254,808.21457,468,522.922,377,386,404.911,698,853,304.43
  投资活动产生的现金流量净额-1,168,615,041.09-70,928,522.92-338,511,394.37-244,872,397.4
三、筹资活动产生的现金流量:
  取得借款收到的现金250,000,00010,000,0003,204,584.27-
  收到其他与筹资活动有关的现金150,000,000110,000,000550,000,000395,000,000
  筹资活动现金流入小计400,000,000120,000,000553,204,584.27395,000,000
  偿还债务支付的现金3,204,584.27---
  分配股利、利润或偿付利息支付的现金1,082,141.62-36,427,720.3127,851,854.38
  支付其他与筹资活动有关的现金481,154,362.019,533,661.592,584,988.2227,081,397.3
  筹资活动现金流出小计485,441,087.99,533,661.5129,012,708.5354,933,251.68
  筹资活动产生的现金流量净额-85,441,087.9110,466,338.5424,191,875.74340,066,748.32
四、汇率变动对现金及现金等价物的影响-42,772,218.35-3,622,231.8520,266,233.723,766,164.25
五、现金及现金等价物净增加额1,479,313,482.56-143,604,190.15-89,745,856.26-56,161,044.76
  加:期初现金及现金等价物余额769,236,836.93769,236,836.93858,982,693.19858,982,693.19
  期末现金及现金等价物余额2,248,550,319.49625,632,646.78769,236,836.93802,821,648.43
补充资料:
  净利润1,551,453,541.91--609,336,030.7-
  资产减值准备4,603,562.05-14,154,894.24-
  固定资产和投资性房地产折旧117,927,859.4-215,877,904.65-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧117,927,859.4-215,877,904.65-
  无形资产摊销3,187,013.96-6,376,182.37-
  处置固定资产、无形资产和其他长期资产的损失262,554.51--2,782,751.39-
  固定资产报废损失62,353.22-3,656,734.48-
  公允价值变动损失-5,954,210.29--17,968,873.4-
  财务费用62,934,847.55-3,262,010.68-
  投资损失193,291.44-14,112,785.93-
  递延所得税3,539,703.95-288,793.39-
  其中:递延所得税资产减少3,151,023.92--175,703.65-
    递延所得税负债增加388,680.03-464,497.04-
  存货的减少78,481,776.04--102,407,873.33-
  经营性应收项目的减少-93,551,252.54--203,084,409.89-
  经营性应付项目的增加1,049,789,164.43-473,240,283.57-
  现金的期末余额2,248,550,319.49-769,236,836.93-
  减:现金的期初余额769,236,836.93-858,982,693.19-
  现金及现金等价物的净增加额1,479,313,482.56--89,745,856.26-
公告日期2026-08-182026-04-282026-03-172025-10-28
审计意见(境内)标准无保留意见
TOP↑